Editors' Desk
-
Outsourcing Lessons From A Biotech Mixologist
1/19/2016
M. (Ken) Kengatharan is an accomplished mixologist. What he mixes professionally is biotech business models, drug researchers and developers, private and venture capital, entrepreneurs and investors … with a large shot of strategic outsourcing. Through his experiences at the five biotechs he’s put together, we can learn how to improve sponsor and service-provider dynamics.
-
Insiders’ Guide To Winning In the Drug Delivery Device Market — Part 1: Design
1/12/2016
As challenges continue to mount in the med device industry, many companies are looking to drug delivery as a new revenue stream. Here, Neil Cammish, technical director, International Device Solutions, discusses the drug delivery technologies poised to have a market impact in 2016 and beyond.
-
EPIRUS Biopharmaceuticals: What Biosimilars Can Learn From The Generics Market
1/12/2016
Though differentiating large-molecule biosimilars from small molecule generics is a staple in biosimilar education, Amit Munshi, CEO of pure-play biosimilar company EPIRUS Biopharmaceuticals, argues the history of the generics market could hold valuable clues as to how the biosimilar market will evolve.
-
Pharmaceutical Outsourcing: What Are You Thinking?
12/17/2015
In this final editorial of 2015, we look into the collective mind of the outsourcing industry, and select a leader of the year. The biopharma industry is now second to none in global consciousness and importance, and the significance of outsourcing within that heightened position grows in equal measure. Prepare well for 2016.
-
Innovators In The Pharmaceutical Packaging Industry
12/11/2015
As biologics and global injectable-drug markets grow, BioPharma needs advancements ensuring the highest quality in the integration of new delivery systems and packaging technologies that can be administered outside of clinical settings. Service providers are responding.
-
How Important Is The Single-Use Supplier Relationship?
12/4/2015
In a survey conducted by Pharma IQ for 2015, which captured the industry’s view on SUT and what challenges it faces, over 100 users were asked about their relationship with their SUT supplier. Of the most important factors identified when choosing a single-use supplier, 64 percent of respondents indicated that the relationship with the supplier ranks as the most important. How important is this as single-use technology adoption increases?
-
The California Drought’s Impact On Pharma
10/22/2015
Drought conditions are making it increasingly difficult for pharmaceutical manufacturers to secure the proper wastewater permits in The Golden State.
-
The Generic And Biosimilar Markets: Are They Really That Different?
10/19/2015
As the FDA continues to compose guidances on the labeling and interchangeability of biosimilar medicines, there remains one big, overarching concern in the industry, and that is making sure biosimilar medicines are not treated as small molecule generics. But should we really be considering the two types of drugs as drastically different as we have been over the past few months?
-
The Evolution Of A Cold Chain Conference
9/28/2015
The Cold Chain Global Forum has grown from a niche conference to the life science industry's leading temperature-controlled event.
-
Performance-Based Pricing Poised To Hit Pharma
9/25/2015
Many call for transparency to combat high drug costs, but outcomes-based pricing is a more realistic solution.